Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Hirschel

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Lancet (London, England)|April 11, 2003
Questions about the antimalarial amodiaquineBernard Hirschel
AIDS (London, England)|April 15, 2004
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et alBernard Hirschel
AIDS (London, England)|April 15, 2004
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et alBernard Hirschel
Lancet (London, England)|August 2, 2005
Effect of rimonabant on weight reduction and cardiovascular riskBernard Hirschel
Revue Medicale Suisse|February 7, 2008
["The new Center will allow the professionalization of patient-oriented clinical research". Interview by Marina Casselyn, Michael Balavoine, Kiefer Bertrand]Bernard Hirschel
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|May 3, 2007
Review on structured treatment interruptions (STIs)Bernard Hirschel
AIDS (London, England)|April 15, 2004
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et alBernard Hirschel
Revue Medicale Suisse|July 13, 2017
Bernard Hirschel
The New England Journal of Medicine|August 29, 2003
Beware of drug holidays before HIV salvage therapyBernard Hirschel
The New England Journal of Medicine|December 19, 2003
Substitution for protease inhibitors in HIV therapyBernard Hirschel
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|April 11, 2003
Questions about the antimalarial amodiaquineBernard Hirschel
AIDS (London, England)|April 15, 2004
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et alBernard Hirschel
AIDS (London, England)|April 15, 2004
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et alBernard Hirschel
Lancet (London, England)|August 2, 2005
Effect of rimonabant on weight reduction and cardiovascular riskBernard Hirschel
Revue Medicale Suisse|February 7, 2008
["The new Center will allow the professionalization of patient-oriented clinical research". Interview by Marina Casselyn, Michael Balavoine, Kiefer Bertrand]Bernard Hirschel
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|May 3, 2007
Review on structured treatment interruptions (STIs)Bernard Hirschel
AIDS (London, England)|April 15, 2004
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et alBernard Hirschel
Revue Medicale Suisse|July 13, 2017
Bernard Hirschel
The New England Journal of Medicine|August 29, 2003
Beware of drug holidays before HIV salvage therapyBernard Hirschel
The New England Journal of Medicine|December 19, 2003
Substitution for protease inhibitors in HIV therapyBernard Hirschel
Pageof 22